

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 8.11258450 |
| 2 | regulation of integrin activation (GO:0033623) | 6.79597291 |
| 3 | positive regulation of actin filament depolymerization (GO:0030836) | 6.48445495 |
| 4 | regulation of vitamin metabolic process (GO:0030656) | 6.44252427 |
| 5 | response to peptidoglycan (GO:0032494) | 6.42340232 |
| 6 | detection of bacterium (GO:0016045) | 6.31583692 |
| 7 | detection of other organism (GO:0098543) | 6.07496874 |
| 8 | regulation of heat generation (GO:0031650) | 5.51413200 |
| 9 | regulation of podosome assembly (GO:0071801) | 5.31574514 |
| 10 | thrombin receptor signaling pathway (GO:0070493) | 5.21401276 |
| 11 | regulation of chronic inflammatory response (GO:0002676) | 5.15530334 |
| 12 | detection of external biotic stimulus (GO:0098581) | 5.14940309 |
| 13 | regulation of cytokine secretion involved in immune response (GO:0002739) | 5.06235539 |
| 14 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 5.01799035 |
| 15 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.96928525 |
| 16 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.94556446 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.77151685 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.77151685 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 4.77151685 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.77151685 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 4.77151685 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.77151685 |
| 23 | cellular extravasation (GO:0045123) | 4.56806562 |
| 24 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.48971642 |
| 25 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 4.47977741 |
| 26 | detection of biotic stimulus (GO:0009595) | 4.47718223 |
| 27 | negative regulation of amino acid transport (GO:0051956) | 4.45885832 |
| 28 | desmosome organization (GO:0002934) | 4.42438092 |
| 29 | monocyte chemotaxis (GO:0002548) | 4.26821362 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 4.23917936 |
| 31 | negative regulation by host of viral transcription (GO:0043922) | 4.08387663 |
| 32 | cellular response to nicotine (GO:0071316) | 4.05849765 |
| 33 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.98751391 |
| 34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.98497382 |
| 35 | linoleic acid metabolic process (GO:0043651) | 3.97539877 |
| 36 | chronic inflammatory response (GO:0002544) | 3.94823246 |
| 37 | cytokine secretion (GO:0050663) | 3.93725732 |
| 38 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.92441620 |
| 39 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.90718337 |
| 40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.85887793 |
| 41 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.82754526 |
| 42 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.80089800 |
| 43 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.75973057 |
| 44 | protein kinase C signaling (GO:0070528) | 3.73420599 |
| 45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.71620074 |
| 46 | regulation of immunoglobulin secretion (GO:0051023) | 3.68266143 |
| 47 | positive regulation of hemostasis (GO:1900048) | 3.67469607 |
| 48 | positive regulation of blood coagulation (GO:0030194) | 3.67469607 |
| 49 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.64550585 |
| 50 | negative regulation of lipid storage (GO:0010888) | 3.64116621 |
| 51 | lipoxygenase pathway (GO:0019372) | 3.63465794 |
| 52 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.61271589 |
| 53 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.60988651 |
| 54 | positive regulation of acute inflammatory response (GO:0002675) | 3.58234492 |
| 55 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.56625320 |
| 56 | cellular response to lipopolysaccharide (GO:0071222) | 3.56579944 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.52569710 |
| 58 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.51372636 |
| 59 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.50678742 |
| 60 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.49089511 |
| 61 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.46867493 |
| 62 | cellular copper ion homeostasis (GO:0006878) | 3.46355756 |
| 63 | neutrophil chemotaxis (GO:0030593) | 3.43714310 |
| 64 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.43584632 |
| 65 | cellular response to molecule of bacterial origin (GO:0071219) | 3.40999554 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 3.40147723 |
| 67 | positive regulation of lymphocyte migration (GO:2000403) | 3.40145366 |
| 68 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.39644768 |
| 69 | regulation of fever generation (GO:0031620) | 3.39387802 |
| 70 | germinal center formation (GO:0002467) | 3.36204699 |
| 71 | negative regulation of interleukin-12 production (GO:0032695) | 3.36052477 |
| 72 | reactive oxygen species biosynthetic process (GO:1903409) | 3.36001515 |
| 73 | positive regulation of coagulation (GO:0050820) | 3.34474564 |
| 74 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.34466500 |
| 75 | superoxide anion generation (GO:0042554) | 3.34445625 |
| 76 | neutrophil migration (GO:1990266) | 3.34139133 |
| 77 | response to protozoan (GO:0001562) | 3.33197592 |
| 78 | activation of MAPKKK activity (GO:0000185) | 3.31645228 |
| 79 | positive regulation of heat generation (GO:0031652) | 3.27885916 |
| 80 | neutrophil activation involved in immune response (GO:0002283) | 3.26987765 |
| 81 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.23250585 |
| 82 | positive regulation of mast cell degranulation (GO:0043306) | 3.23250585 |
| 83 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.22613163 |
| 84 | negative regulation of interleukin-17 production (GO:0032700) | 3.22431415 |
| 85 | regulation of prostaglandin secretion (GO:0032306) | 3.19235377 |
| 86 | positive regulation of macrophage cytokine production (GO:0060907) | 3.19084214 |
| 87 | negative regulation of organic acid transport (GO:0032891) | 3.17758383 |
| 88 | inflammatory response to antigenic stimulus (GO:0002437) | 3.17141804 |
| 89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.16640350 |
| 90 | macrophage activation involved in immune response (GO:0002281) | 3.15430555 |
| 91 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.14561739 |
| 92 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.14129132 |
| 93 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.09964917 |
| 94 | heart valve formation (GO:0003188) | 3.09778605 |
| 95 | positive regulation of prostaglandin secretion (GO:0032308) | 3.09614344 |
| 96 | cellular response to type I interferon (GO:0071357) | 3.09474281 |
| 97 | type I interferon signaling pathway (GO:0060337) | 3.09474281 |
| 98 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.08552947 |
| 99 | regulation of growth of symbiont in host (GO:0044126) | 3.08552947 |
| 100 | negative regulation of growth of symbiont in host (GO:0044130) | 3.08552947 |
| 101 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.08552947 |
| 102 | positive regulation of transcription factor import into nucleus (GO:0042993) | 3.08519430 |
| 103 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.07096946 |
| 104 | T-helper 1 type immune response (GO:0042088) | 3.05920602 |
| 105 | positive regulation of type 2 immune response (GO:0002830) | 3.05666640 |
| 106 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.05588655 |
| 107 | positive regulation of chemokine production (GO:0032722) | 3.05308063 |
| 108 | low-density lipoprotein particle clearance (GO:0034383) | 3.05065008 |
| 109 | response to type I interferon (GO:0034340) | 3.04967158 |
| 110 | gap junction assembly (GO:0016264) | 3.03865345 |
| 111 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.02581628 |
| 112 | negative regulation of membrane potential (GO:0045837) | 3.00466545 |
| 113 | granulocyte chemotaxis (GO:0071621) | 2.99619029 |
| 114 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.98722883 |
| 115 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.98692609 |
| 116 | granulocyte activation (GO:0036230) | 2.98182101 |
| 117 | response to muramyl dipeptide (GO:0032495) | 2.98139936 |
| 118 | eosinophil chemotaxis (GO:0048245) | 2.98099432 |
| 119 | glycosphingolipid catabolic process (GO:0046479) | 2.96419775 |
| 120 | negative regulation of T cell mediated immunity (GO:0002710) | 2.95947724 |
| 121 | cellular response to biotic stimulus (GO:0071216) | 2.95711879 |
| 122 | regulation of interleukin-6 production (GO:0032675) | 2.94518382 |
| 123 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.93917837 |
| 124 | regulation of lymphocyte migration (GO:2000401) | 2.92895206 |
| 125 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.91906532 |
| 126 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.91665120 |
| 127 | positive regulation of interleukin-10 production (GO:0032733) | 2.91490903 |
| 128 | defense response to protozoan (GO:0042832) | 2.90766766 |
| 129 | oligosaccharide catabolic process (GO:0009313) | 2.90446505 |
| 130 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.89703154 |
| 131 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.87408036 |
| 132 | neutrophil mediated immunity (GO:0002446) | 2.86962271 |
| 133 | regulation of mast cell degranulation (GO:0043304) | 2.86085389 |
| 134 | granulocyte migration (GO:0097530) | 2.85419463 |
| 135 | myeloid dendritic cell differentiation (GO:0043011) | 2.83190711 |
| 136 | negative regulation of glucose transport (GO:0010829) | 2.82387903 |
| 137 | positive regulation of mast cell activation (GO:0033005) | 2.82117303 |
| 138 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.81328517 |
| 139 | xenobiotic catabolic process (GO:0042178) | 2.80594865 |
| 140 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.80102771 |
| 141 | leukocyte aggregation (GO:0070486) | 2.79904770 |
| 142 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.79143239 |
| 143 | adhesion of symbiont to host cell (GO:0044650) | 2.78824836 |
| 144 | virion attachment to host cell (GO:0019062) | 2.78824836 |
| 145 | positive regulation of interleukin-6 production (GO:0032755) | 2.78609734 |
| 146 | response to ATP (GO:0033198) | 2.78361683 |
| 147 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.78053959 |
| 148 | respiratory burst (GO:0045730) | 2.76049467 |
| 149 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.75600548 |
| 150 | positive regulation of interferon-alpha production (GO:0032727) | 2.74567370 |
| 151 | regulation of mononuclear cell migration (GO:0071675) | 2.73258146 |
| 152 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.72747306 |
| 153 | regulation of interleukin-12 production (GO:0032655) | 2.72638256 |
| 154 | positive regulation of cytokine secretion (GO:0050715) | 2.72221042 |
| 155 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.71915988 |
| 156 | microglial cell activation (GO:0001774) | 2.71672673 |
| 157 | regulation of chemokine biosynthetic process (GO:0045073) | 2.71372962 |
| 158 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.70512248 |
| 159 | nitric oxide mediated signal transduction (GO:0007263) | 2.69745547 |
| 160 | cortical actin cytoskeleton organization (GO:0030866) | 2.69145616 |
| 161 | ovulation (GO:0030728) | 2.68739162 |
| 162 | response to manganese ion (GO:0010042) | 2.68513151 |
| 163 | regulation of B cell differentiation (GO:0045577) | 2.67735381 |
| 164 | regulation of water loss via skin (GO:0033561) | 2.64228758 |
| 165 | regulation of gonadotropin secretion (GO:0032276) | 2.64032430 |
| 166 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.63429633 |
| 167 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.63423974 |
| 168 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.63137634 |
| 169 | response to host immune response (GO:0052572) | 2.62700755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.84548102 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.29585854 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.27644839 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.24771127 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.67883315 |
| 6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.57547329 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.52005830 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41050574 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32998379 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.32449678 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.32079628 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16416193 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.08761094 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.04632504 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 11.3201986 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.95799331 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83378514 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79486634 |
| 19 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.77484026 |
| 20 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74164628 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.69490952 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.63479582 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62654901 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60853877 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55799641 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.48151494 |
| 27 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48099356 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44478549 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41616552 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40254527 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38583679 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.36359968 |
| 33 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.34500027 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33793223 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32710159 |
| 36 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.30563121 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29313292 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29027903 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28600964 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25054183 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25028637 |
| 42 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.24857190 |
| 43 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.23100497 |
| 44 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.23100497 |
| 45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21668089 |
| 46 | RXR_22108803_ChIP-Seq_LS180_Human | 1.20068922 |
| 47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19480521 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19324361 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19315003 |
| 50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19059312 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17174937 |
| 52 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17085805 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16016316 |
| 54 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15279117 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.14912249 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13762804 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11297253 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10099717 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09134310 |
| 60 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.08735974 |
| 61 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.08735974 |
| 62 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.08735974 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.08058807 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07808602 |
| 65 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07231836 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03097047 |
| 67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02520205 |
| 68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02235935 |
| 69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02058226 |
| 70 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00896948 |
| 71 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98368543 |
| 72 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97073740 |
| 73 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96462021 |
| 74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.95553155 |
| 75 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95552266 |
| 76 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95382050 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95217234 |
| 78 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94613285 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94051990 |
| 80 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.93558188 |
| 81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93433640 |
| 82 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93195035 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93138548 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92500722 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92369868 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91788697 |
| 87 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91006705 |
| 88 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90992718 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.90460145 |
| 90 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89700141 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89461202 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87498906 |
| 93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87498906 |
| 94 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85023339 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84958937 |
| 96 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84852716 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84774874 |
| 98 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.84477810 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83930357 |
| 100 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82611036 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82461727 |
| 102 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82320541 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82270664 |
| 104 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.82227521 |
| 105 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.81040219 |
| 106 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80482500 |
| 107 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.80366269 |
| 108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80138678 |
| 109 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.79276621 |
| 110 | UTX_26944678_Chip-Seq_JUKART_Human | 0.79275892 |
| 111 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.78838272 |
| 112 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78815253 |
| 113 | MYB_26560356_Chip-Seq_TH1_Human | 0.77935309 |
| 114 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77646622 |
| 115 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.77515333 |
| 116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76405757 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74802575 |
| 118 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.74484091 |
| 119 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.73607249 |
| 120 | VDR_22108803_ChIP-Seq_LS180_Human | 0.73253825 |
| 121 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72564474 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.71987446 |
| 123 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.71203079 |
| 124 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70011522 |
| 125 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.68112223 |
| 126 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.67917406 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.66999048 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66753460 |
| 129 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.66395684 |
| 130 | GATA3_26560356_Chip-Seq_TH2_Human | 0.64827996 |
| 131 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.64773528 |
| 132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.64228190 |
| 133 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.64093487 |
| 134 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.64001353 |
| 135 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.63412343 |
| 136 | SPI1_23127762_ChIP-Seq_K562_Human | 0.63367938 |
| 137 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63194551 |
| 138 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.62762937 |
| 139 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.62627683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.25596651 |
| 2 | MP0009785_altered_susceptibility_to | 4.19183457 |
| 3 | MP0003436_decreased_susceptibility_to | 3.57153545 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.47297217 |
| 5 | MP0002419_abnormal_innate_immunity | 3.07051765 |
| 6 | MP0009840_abnormal_foam_cell | 2.95434714 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.79244731 |
| 8 | MP0005025_abnormal_response_to | 2.73109183 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.73046465 |
| 10 | MP0004947_skin_inflammation | 2.69937054 |
| 11 | MP0003453_abnormal_keratinocyte_physiol | 2.68569740 |
| 12 | MP0003828_pulmonary_edema | 2.55996485 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.53398839 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.53083802 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.45736830 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.41446802 |
| 17 | MP0002254_reproductive_system_inflammat | 2.35995747 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.34951420 |
| 19 | MP0009764_decreased_sensitivity_to | 2.33288253 |
| 20 | MP0006082_CNS_inflammation | 2.31678258 |
| 21 | MP0002796_impaired_skin_barrier | 2.27789673 |
| 22 | MP0008004_abnormal_stomach_pH | 2.26136485 |
| 23 | MP0000383_abnormal_hair_follicle | 2.18065648 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.13601254 |
| 25 | MP0005451_abnormal_body_composition | 2.10178062 |
| 26 | MP0003075_altered_response_to | 2.02415620 |
| 27 | MP0001790_abnormal_immune_system | 1.95860985 |
| 28 | MP0005387_immune_system_phenotype | 1.95860985 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.95383875 |
| 30 | MP0005275_abnormal_skin_tensile | 1.95251810 |
| 31 | MP0003303_peritoneal_inflammation | 1.94353159 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.93701711 |
| 33 | MP0002723_abnormal_immune_serum | 1.92068971 |
| 34 | MP0006054_spinal_hemorrhage | 1.89155659 |
| 35 | MP0001800_abnormal_humoral_immune | 1.84242371 |
| 36 | MP0002933_joint_inflammation | 1.83845988 |
| 37 | MP0002098_abnormal_vibrissa_morphology | 1.76738713 |
| 38 | MP0002006_tumorigenesis | 1.75206521 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.68344835 |
| 40 | MP0000343_altered_response_to | 1.66699007 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.63023284 |
| 42 | MP0001819_abnormal_immune_cell | 1.62354040 |
| 43 | MP0010678_abnormal_skin_adnexa | 1.61718863 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.60966364 |
| 45 | MP0001216_abnormal_epidermal_layer | 1.58661985 |
| 46 | MP0003941_abnormal_skin_development | 1.57381099 |
| 47 | MP0002060_abnormal_skin_morphology | 1.56852497 |
| 48 | MP0005165_increased_susceptibility_to | 1.55756300 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.55079713 |
| 50 | MP0000604_amyloidosis | 1.51575019 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.49755441 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.49755441 |
| 53 | MP0002405_respiratory_system_inflammati | 1.45593636 |
| 54 | MP0003195_calcinosis | 1.45242780 |
| 55 | MP0001853_heart_inflammation | 1.37920428 |
| 56 | MP0010771_integument_phenotype | 1.36881563 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.35184705 |
| 58 | MP0000566_synostosis | 1.34962178 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.34326997 |
| 60 | MP0000579_abnormal_nail_morphology | 1.34017961 |
| 61 | MP0005623_abnormal_meninges_morphology | 1.32730245 |
| 62 | MP0008469_abnormal_protein_level | 1.30778331 |
| 63 | MP0004381_abnormal_hair_follicle | 1.27239635 |
| 64 | MP0005390_skeleton_phenotype | 1.25592672 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.23842848 |
| 66 | MP0002295_abnormal_pulmonary_circulatio | 1.21968513 |
| 67 | MP0005166_decreased_susceptibility_to | 1.21384907 |
| 68 | MP0005171_absent_coat_pigmentation | 1.17805543 |
| 69 | MP0003448_altered_tumor_morphology | 1.16784257 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.14265596 |
| 71 | MP0001501_abnormal_sleep_pattern | 1.12557234 |
| 72 | MP0001191_abnormal_skin_condition | 1.10656775 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 1.10414084 |
| 74 | MP0005310_abnormal_salivary_gland | 1.09997724 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 1.07125139 |
| 76 | MP0005023_abnormal_wound_healing | 1.06166045 |
| 77 | MP0005501_abnormal_skin_physiology | 1.05784381 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 1.03513430 |
| 79 | MP0001243_abnormal_dermal_layer | 1.00772864 |
| 80 | MP0003880_abnormal_central_pattern | 0.99928710 |
| 81 | MP0000685_abnormal_immune_system | 0.99639176 |
| 82 | MP0001542_abnormal_bone_strength | 0.98664933 |
| 83 | MP0000920_abnormal_myelination | 0.95974349 |
| 84 | MP0005164_abnormal_response_to | 0.95372275 |
| 85 | MP0003091_abnormal_cell_migration | 0.94826653 |
| 86 | MP0009697_abnormal_copulation | 0.94685926 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.94655660 |
| 88 | MP0005085_abnormal_gallbladder_physiolo | 0.93100335 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 0.91940655 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.89155941 |
| 91 | MP0003186_abnormal_redox_activity | 0.85531681 |
| 92 | MP0009763_increased_sensitivity_to | 0.83226000 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.83042692 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.82775726 |
| 95 | MP0004510_myositis | 0.82529052 |
| 96 | MP0005647_abnormal_sex_gland | 0.82224800 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.80143661 |
| 98 | MP0000858_altered_metastatic_potential | 0.80088824 |
| 99 | MP0009278_abnormal_bone_marrow | 0.78925402 |
| 100 | MP0003690_abnormal_glial_cell | 0.78136906 |
| 101 | MP0005535_abnormal_body_temperature | 0.76497076 |
| 102 | MP0005671_abnormal_response_to | 0.76400122 |
| 103 | MP0000367_abnormal_coat/_hair | 0.75712080 |
| 104 | MP0001663_abnormal_digestive_system | 0.75668918 |
| 105 | MP0008438_abnormal_cutaneous_collagen | 0.75357611 |
| 106 | * MP0000716_abnormal_immune_system | 0.74738780 |
| 107 | MP0003646_muscle_fatigue | 0.72955945 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.72590670 |
| 109 | MP0000249_abnormal_blood_vessel | 0.72566374 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.71534605 |
| 111 | MP0008874_decreased_physiological_sensi | 0.71059699 |
| 112 | MP0005257_abnormal_intraocular_pressure | 0.70870830 |
| 113 | MP0009931_abnormal_skin_appearance | 0.70779835 |
| 114 | * MP0002398_abnormal_bone_marrow | 0.70706045 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 0.70366192 |
| 116 | MP0004883_abnormal_blood_vessel | 0.70345563 |
| 117 | MP0002133_abnormal_respiratory_system | 0.69170875 |
| 118 | MP0005388_respiratory_system_phenotype | 0.69170875 |
| 119 | MP0001851_eye_inflammation | 0.69081935 |
| 120 | MP0002736_abnormal_nociception_after | 0.68627115 |
| 121 | * MP0002429_abnormal_blood_cell | 0.68239146 |
| 122 | MP0003252_abnormal_bile_duct | 0.68009495 |
| 123 | MP0000467_abnormal_esophagus_morphology | 0.67525601 |
| 124 | MP0000371_diluted_coat_color | 0.65498302 |
| 125 | MP0001346_abnormal_lacrimal_gland | 0.65277452 |
| 126 | MP0002722_abnormal_immune_system | 0.64931529 |
| 127 | MP0003795_abnormal_bone_structure | 0.63601044 |
| 128 | MP0001727_abnormal_embryo_implantation | 0.63581988 |
| 129 | MP0003329_amyloid_beta_deposits | 0.61016258 |
| 130 | MP0005595_abnormal_vascular_smooth | 0.59442213 |
| 131 | MP0000689_abnormal_spleen_morphology | 0.58734325 |
| 132 | MP0005266_abnormal_metabolism | 0.58032344 |
| 133 | MP0002138_abnormal_hepatobiliary_system | 0.57694637 |
| 134 | MP0010307_abnormal_tumor_latency | 0.53568071 |
| 135 | MP0000750_abnormal_muscle_regeneration | 0.53343933 |
| 136 | MP0003045_fibrosis | 0.52584727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 8.31701949 |
| 2 | Recurrent abscess formation (HP:0002722) | 7.68714147 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.09011548 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.09011548 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 7.09011548 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 6.74788684 |
| 7 | Interstitial pulmonary disease (HP:0006530) | 6.32058868 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 6.20653948 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 5.64897962 |
| 10 | Eczematoid dermatitis (HP:0000976) | 5.60157499 |
| 11 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 5.27474959 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.10648632 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 5.07205313 |
| 14 | Loss of speech (HP:0002371) | 4.54201530 |
| 15 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.51353411 |
| 16 | Dysostosis multiplex (HP:0000943) | 4.45073320 |
| 17 | Thick nail (HP:0001805) | 4.37213737 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 4.31001979 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.89857904 |
| 20 | Nuclear cataract (HP:0100018) | 3.85301875 |
| 21 | Gingivitis (HP:0000230) | 3.80690223 |
| 22 | Pustule (HP:0200039) | 3.79352851 |
| 23 | Mutism (HP:0002300) | 3.77290948 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 3.60713352 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 3.54590310 |
| 26 | Fused cervical vertebrae (HP:0002949) | 3.50080699 |
| 27 | Apathy (HP:0000741) | 3.38523288 |
| 28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.30910205 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.30910205 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.30910205 |
| 31 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.30525929 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.27810152 |
| 33 | Diminished motivation (HP:0000745) | 3.25213989 |
| 34 | Keratoconjunctivitis (HP:0001096) | 3.21323985 |
| 35 | Nausea (HP:0002018) | 3.14662687 |
| 36 | Parakeratosis (HP:0001036) | 3.11832899 |
| 37 | Mucopolysacchariduria (HP:0008155) | 3.11807917 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.11807917 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.98422191 |
| 40 | Recurrent skin infections (HP:0001581) | 2.94408316 |
| 41 | Plantar hyperkeratosis (HP:0007556) | 2.93476796 |
| 42 | Right ventricular cardiomyopathy (HP:0011663) | 2.88755324 |
| 43 | Obstructive lung disease (HP:0006536) | 2.87411123 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87411123 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.82036953 |
| 46 | Spinal muscular atrophy (HP:0007269) | 2.80637171 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.80035625 |
| 48 | Increased serum ferritin (HP:0003281) | 2.77527524 |
| 49 | Amyloidosis (HP:0011034) | 2.70488748 |
| 50 | Periodontitis (HP:0000704) | 2.69803493 |
| 51 | Increased IgE level (HP:0003212) | 2.68654004 |
| 52 | Petechiae (HP:0000967) | 2.66667473 |
| 53 | Axonal loss (HP:0003447) | 2.66081792 |
| 54 | Glomerulonephritis (HP:0000099) | 2.63959569 |
| 55 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.62815862 |
| 56 | Palmoplantar hyperkeratosis (HP:0000972) | 2.62339111 |
| 57 | Polyneuropathy (HP:0001271) | 2.57816083 |
| 58 | Purpura (HP:0000979) | 2.57490392 |
| 59 | Neuronal loss in central nervous system (HP:0002529) | 2.57446741 |
| 60 | Palmar hyperkeratosis (HP:0010765) | 2.54794795 |
| 61 | Premature loss of primary teeth (HP:0006323) | 2.53175125 |
| 62 | Atrioventricular block (HP:0001678) | 2.52845137 |
| 63 | Joint swelling (HP:0001386) | 2.51631466 |
| 64 | Cellulitis (HP:0100658) | 2.50643984 |
| 65 | Inappropriate behavior (HP:0000719) | 2.47447183 |
| 66 | Recurrent fungal infections (HP:0002841) | 2.46296283 |
| 67 | Vasculitis (HP:0002633) | 2.44112536 |
| 68 | Colitis (HP:0002583) | 2.44024810 |
| 69 | Progressive neurologic deterioration (HP:0002344) | 2.43137997 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.40171007 |
| 71 | Optic neuritis (HP:0100653) | 2.40171007 |
| 72 | Orchitis (HP:0100796) | 2.37613250 |
| 73 | Corneal erosion (HP:0200020) | 2.34331640 |
| 74 | Milia (HP:0001056) | 2.33022811 |
| 75 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.32874734 |
| 76 | Myositis (HP:0100614) | 2.31907149 |
| 77 | Sepsis (HP:0100806) | 2.31804020 |
| 78 | Metaphyseal irregularity (HP:0003025) | 2.29624012 |
| 79 | Disinhibition (HP:0000734) | 2.29135422 |
| 80 | Urticaria (HP:0001025) | 2.24681306 |
| 81 | Bone pain (HP:0002653) | 2.23886232 |
| 82 | Woolly hair (HP:0002224) | 2.23591091 |
| 83 | Hypotrichosis (HP:0001006) | 2.22882547 |
| 84 | Gangrene (HP:0100758) | 2.21143720 |
| 85 | Pruritus (HP:0000989) | 2.20345038 |
| 86 | Lip pit (HP:0100267) | 2.18835963 |
| 87 | Sex reversal (HP:0012245) | 2.18679380 |
| 88 | Abnormal sex determination (HP:0012244) | 2.18679380 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.17338421 |
| 90 | Prolonged neonatal jaundice (HP:0006579) | 2.15410773 |
| 91 | Abnormality of the pericardium (HP:0001697) | 2.15224704 |
| 92 | Tetraparesis (HP:0002273) | 2.14278621 |
| 93 | Erythroderma (HP:0001019) | 2.13569042 |
| 94 | Nephritis (HP:0000123) | 2.11190467 |
| 95 | Progressive visual loss (HP:0000529) | 2.09376329 |
| 96 | Arterial thrombosis (HP:0004420) | 2.08473139 |
| 97 | Asymmetric septal hypertrophy (HP:0001670) | 2.08441009 |
| 98 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.08004085 |
| 99 | Osteolytic defects of the hand bones (HP:0009699) | 2.08004085 |
| 100 | IgM deficiency (HP:0002850) | 2.07614264 |
| 101 | Increased IgM level (HP:0003496) | 2.06571523 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.05949652 |
| 103 | Erythema (HP:0010783) | 2.05898939 |
| 104 | Hemoptysis (HP:0002105) | 2.05290881 |
| 105 | Recurrent viral infections (HP:0004429) | 2.04791341 |
| 106 | Abnormality of complement system (HP:0005339) | 2.03741485 |
| 107 | Supranuclear gaze palsy (HP:0000605) | 2.03184545 |
| 108 | Episodic fever (HP:0001954) | 2.02949088 |
| 109 | Peritonitis (HP:0002586) | 2.01719763 |
| 110 | Hypohidrosis (HP:0000966) | 2.00877056 |
| 111 | Vertigo (HP:0002321) | 1.99578991 |
| 112 | Pulmonary infiltrates (HP:0002113) | 1.99229183 |
| 113 | Osteomyelitis (HP:0002754) | 1.99081293 |
| 114 | Clumsiness (HP:0002312) | 1.98311000 |
| 115 | Myocardial infarction (HP:0001658) | 1.97207963 |
| 116 | Submucous cleft hard palate (HP:0000176) | 1.90818208 |
| 117 | Vertebral compression fractures (HP:0002953) | 1.89821311 |
| 118 | Prolonged partial thromboplastin time (HP:0003645) | 1.89160915 |
| 119 | Personality changes (HP:0000751) | 1.89070524 |
| 120 | Dementia (HP:0000726) | 1.88704561 |
| 121 | Spontaneous hematomas (HP:0007420) | 1.88499133 |
| 122 | Leukocytosis (HP:0001974) | 1.88131748 |
| 123 | Basal ganglia calcification (HP:0002135) | 1.86746668 |
| 124 | Abnormality of the pleura (HP:0002103) | 1.86582501 |
| 125 | T lymphocytopenia (HP:0005403) | 1.86056955 |
| 126 | Malnutrition (HP:0004395) | 1.85475498 |
| 127 | Alopecia of scalp (HP:0002293) | 1.85268387 |
| 128 | Hypergammaglobulinemia (HP:0010702) | 1.85103413 |
| 129 | Onycholysis (HP:0001806) | 1.83521678 |
| 130 | Anorexia (HP:0002039) | 1.81759671 |
| 131 | Memory impairment (HP:0002354) | 1.80760067 |
| 132 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.80100422 |
| 133 | Peripheral demyelination (HP:0011096) | 1.80064726 |
| 134 | Complement deficiency (HP:0004431) | 1.79927750 |
| 135 | Gingival bleeding (HP:0000225) | 1.79233108 |
| 136 | Skin ulcer (HP:0200042) | 1.79194345 |
| 137 | Arthralgia (HP:0002829) | 1.79062227 |
| 138 | Abnormal atrioventricular conduction (HP:0005150) | 1.79006296 |
| 139 | Keratitis (HP:0000491) | 1.78162499 |
| 140 | Natal tooth (HP:0000695) | 1.76817099 |
| 141 | Hepatosplenomegaly (HP:0001433) | 1.73352957 |
| 142 | Thin bony cortex (HP:0002753) | 1.72119489 |
| 143 | Ectropion (HP:0000656) | 1.71905291 |
| 144 | Arterial tortuosity (HP:0005116) | 1.71252343 |
| 145 | Increased CSF protein (HP:0002922) | 1.71037976 |
| 146 | White forelock (HP:0002211) | 1.70922087 |
| 147 | Meningitis (HP:0001287) | 1.69873907 |
| 148 | Hematochezia (HP:0002573) | 1.69857568 |
| 149 | Fragile nails (HP:0001808) | 1.68916281 |
| 150 | Aplasia cutis congenita (HP:0001057) | 1.67572788 |
| 151 | Heart block (HP:0012722) | 1.66657989 |
| 152 | Respiratory distress (HP:0002098) | 1.66054275 |
| 153 | Chronic otitis media (HP:0000389) | 1.65447991 |
| 154 | Agnosia (HP:0010524) | 1.64331126 |
| 155 | Rectal fistula (HP:0100590) | 1.60322894 |
| 156 | Rectovaginal fistula (HP:0000143) | 1.60322894 |
| 157 | Polygenic inheritance (HP:0010982) | 1.60247704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 9.20200676 |
| 2 | IRAK3 | 4.24519478 |
| 3 | MAP4K1 | 4.05084205 |
| 4 | TXK | 3.92244561 |
| 5 | TAOK2 | 3.14842792 |
| 6 | NME2 | 3.10965369 |
| 7 | BMPR1B | 2.55477796 |
| 8 | ADRBK1 | 2.35897581 |
| 9 | RIPK1 | 2.08513239 |
| 10 | MST4 | 2.06799273 |
| 11 | RIPK4 | 2.03843349 |
| 12 | MOS | 1.92618764 |
| 13 | MAP3K14 | 1.90979859 |
| 14 | PRPF4B | 1.90013253 |
| 15 | STK10 | 1.86115465 |
| 16 | MST1R | 1.85791266 |
| 17 | EPHB1 | 1.83176312 |
| 18 | MAP3K11 | 1.74689318 |
| 19 | TBK1 | 1.67833365 |
| 20 | CDC42BPA | 1.56424199 |
| 21 | ZAP70 | 1.54008152 |
| 22 | TYRO3 | 1.41461926 |
| 23 | IKBKB | 1.40991507 |
| 24 | NEK9 | 1.40466699 |
| 25 | LRRK2 | 1.37084178 |
| 26 | FGR | 1.36237224 |
| 27 | MAP2K3 | 1.35851184 |
| 28 | IRAK2 | 1.35174341 |
| 29 | EPHA3 | 1.34855457 |
| 30 | PRKCD | 1.31801935 |
| 31 | SYK | 1.25814439 |
| 32 | STK24 | 1.25241112 |
| 33 | ERBB3 | 1.23908673 |
| 34 | TYK2 | 1.23388579 |
| 35 | SIK3 | 1.20307940 |
| 36 | GRK7 | 1.17524436 |
| 37 | LYN | 1.17208975 |
| 38 | PDGFRA | 1.13545022 |
| 39 | FGFR4 | 1.10678595 |
| 40 | MAP3K13 | 1.09652935 |
| 41 | MAP3K5 | 1.08738574 |
| 42 | IKBKE | 1.08246921 |
| 43 | JAK3 | 1.08176808 |
| 44 | JAK1 | 1.03562446 |
| 45 | MAP3K12 | 1.03155535 |
| 46 | TEC | 1.02679123 |
| 47 | ACVR1B | 1.01050332 |
| 48 | PKN1 | 1.00428320 |
| 49 | HCK | 0.99083381 |
| 50 | LATS2 | 0.97005708 |
| 51 | TGFBR1 | 0.95566263 |
| 52 | TRPM7 | 0.94476618 |
| 53 | IRAK4 | 0.94379066 |
| 54 | JAK2 | 0.91913005 |
| 55 | FER | 0.91468495 |
| 56 | TGFBR2 | 0.90671609 |
| 57 | FES | 0.86458520 |
| 58 | MAP3K3 | 0.84285837 |
| 59 | CSK | 0.82998181 |
| 60 | DAPK2 | 0.81727423 |
| 61 | ERBB4 | 0.81507459 |
| 62 | LCK | 0.81338739 |
| 63 | MAP3K1 | 0.80913884 |
| 64 | MATK | 0.76892723 |
| 65 | ERN1 | 0.76798479 |
| 66 | TESK1 | 0.74846029 |
| 67 | PBK | 0.72535454 |
| 68 | ITK | 0.71788267 |
| 69 | CSF1R | 0.69167850 |
| 70 | BMPR2 | 0.68990085 |
| 71 | ARAF | 0.68667496 |
| 72 | KIT | 0.65083259 |
| 73 | EPHA2 | 0.64706100 |
| 74 | IRAK1 | 0.63810191 |
| 75 | NLK | 0.63742387 |
| 76 | BTK | 0.60473817 |
| 77 | FGFR3 | 0.59240670 |
| 78 | PIM2 | 0.59064353 |
| 79 | EGFR | 0.58690319 |
| 80 | BMX | 0.58014410 |
| 81 | CLK1 | 0.55835289 |
| 82 | CDK6 | 0.54968109 |
| 83 | FYN | 0.54207551 |
| 84 | CHUK | 0.53841870 |
| 85 | TAOK3 | 0.53641941 |
| 86 | DDR2 | 0.53397279 |
| 87 | NTRK3 | 0.51844960 |
| 88 | PDGFRB | 0.50751586 |
| 89 | PIM1 | 0.49398640 |
| 90 | EPHB2 | 0.47719336 |
| 91 | ABL1 | 0.46735186 |
| 92 | EIF2AK2 | 0.45564419 |
| 93 | PAK4 | 0.45434177 |
| 94 | DYRK3 | 0.43892695 |
| 95 | MAP3K9 | 0.42422072 |
| 96 | GRK5 | 0.42059478 |
| 97 | PLK2 | 0.41544676 |
| 98 | MAP2K6 | 0.41451147 |
| 99 | ALK | 0.40993876 |
| 100 | KSR2 | 0.39655028 |
| 101 | MELK | 0.39463245 |
| 102 | ICK | 0.37797845 |
| 103 | PAK3 | 0.37625403 |
| 104 | GSK3A | 0.37487773 |
| 105 | MAPKAPK3 | 0.36248209 |
| 106 | DAPK3 | 0.36124265 |
| 107 | PRKCG | 0.34945981 |
| 108 | PTK6 | 0.34249610 |
| 109 | IGF1R | 0.34243708 |
| 110 | PRKCQ | 0.34168242 |
| 111 | PIK3CG | 0.34167110 |
| 112 | RPS6KB2 | 0.33388265 |
| 113 | KSR1 | 0.31392062 |
| 114 | TAOK1 | 0.29689888 |
| 115 | TTN | 0.29142174 |
| 116 | PRKCA | 0.27277504 |
| 117 | PRKCE | 0.26304593 |
| 118 | ADRBK2 | 0.26084450 |
| 119 | RPS6KL1 | 0.26030975 |
| 120 | RPS6KC1 | 0.26030975 |
| 121 | MAPK4 | 0.25350659 |
| 122 | PRKD1 | 0.25191078 |
| 123 | EPHA4 | 0.24320086 |
| 124 | MAP2K1 | 0.23929667 |
| 125 | SRC | 0.23529863 |
| 126 | ABL2 | 0.23132987 |
| 127 | INSR | 0.23116356 |
| 128 | PRKACB | 0.22819368 |
| 129 | MARK3 | 0.21723513 |
| 130 | MAP3K2 | 0.21122790 |
| 131 | PRKACG | 0.19765440 |
| 132 | TESK2 | 0.19499029 |
| 133 | ERBB2 | 0.19137947 |
| 134 | CDK18 | 0.18967839 |
| 135 | CDK14 | 0.18709279 |
| 136 | HIPK2 | 0.18005749 |
| 137 | RPS6KA6 | 0.17893950 |
| 138 | CDK15 | 0.17726714 |
| 139 | CDK11A | 0.13631957 |
| 140 | STK3 | 0.12666305 |
| 141 | BRAF | 0.12256009 |
| 142 | LIMK1 | 0.12185473 |
| 143 | CAMKK2 | 0.11262324 |
| 144 | MAPK7 | 0.11090477 |
| 145 | MAPKAPK2 | 0.10419905 |
| 146 | CAMK1D | 0.08909165 |
| 147 | MAP3K8 | 0.08846473 |
| 148 | PDK1 | 0.08738634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 6.73573422 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.64806118 |
| 3 | Legionellosis_Homo sapiens_hsa05134 | 3.20536709 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.93111272 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.69719930 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.44692768 |
| 7 | Salmonella infection_Homo sapiens_hsa05132 | 2.32048591 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.29421711 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.28272241 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.25684801 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24012088 |
| 12 | Amoebiasis_Homo sapiens_hsa05146 | 2.21473920 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07513424 |
| 14 | Malaria_Homo sapiens_hsa05144 | 2.05003207 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 2.01927802 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.88560323 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85555798 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84295175 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.73855538 |
| 20 | Phagosome_Homo sapiens_hsa04145 | 1.66710711 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.61897761 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50056696 |
| 23 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.48916658 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47294309 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.43069731 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37625894 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.28464663 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22803545 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19217821 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17088551 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.16491908 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07436689 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07370555 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05768388 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05157584 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04787626 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.04314074 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99737041 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98951251 |
| 40 | Asthma_Homo sapiens_hsa05310 | 0.98046431 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96010304 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95101636 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95079276 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93990051 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92546227 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88760455 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84718784 |
| 48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83283630 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80190974 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 0.79990159 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79092211 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78395919 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75846880 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.74725133 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71981103 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65676471 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63784155 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63218249 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61885224 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60440595 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60181109 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.60178556 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 0.60166076 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60020496 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59464351 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59274876 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56222872 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55925538 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.55769929 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51828511 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50036353 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49311864 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48541060 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48085896 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47234695 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46604769 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45935465 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45259443 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45258836 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 0.43777670 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.43721332 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42861444 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42451503 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42380547 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41379608 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41204683 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39580328 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39479345 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39069346 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38362593 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38013511 |
| 92 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37361596 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34783283 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32753352 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32643961 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.32489196 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32316486 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.32065338 |
| 99 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31207006 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31055247 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30900697 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29926288 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.29160717 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28038072 |
| 105 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.26795332 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26441918 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.25102909 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24251408 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22430154 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20988538 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.20893607 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19660804 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19602710 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.19489429 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19441060 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18998509 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18644320 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18463654 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.18384137 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.18344923 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17804884 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.17309187 |
| 123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.17074043 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16706515 |
| 125 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16636913 |
| 126 | Retinol metabolism_Homo sapiens_hsa00830 | 0.15975137 |
| 127 | Shigellosis_Homo sapiens_hsa05131 | 0.14814033 |
| 128 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.14731670 |
| 129 | Peroxisome_Homo sapiens_hsa04146 | 0.14347533 |
| 130 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.12560061 |
| 131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12447214 |

